Status: Recruiting
Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function
This is a clinical trial designed to examine how improved sleep through morning bright light therapy is improving downstream key physiologic processes related to brain health, i.e., mitochondrial function, systemic inflammation, and glymphatic function. All proposed methodology is already approved in other IRB applications.
Participants needed: 300
Trial details
Age: 18-89Biological sex: AllType: InterventionalSponsor: Oregon Health and Science UniversityUpdated: May 22, 2026Locations: 1
Eligibility criteria
Male and female; any race; 18-89 years of age. [+20]